Showing results (1021-1030 of 3,636) with videos related to

Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|March 28, 2025
Systematic literature review and trial-level meta-analysis of aromatase inhibitors vs tamoxifen in patients with HR+/HER2- early breast cancerWolfgang Janni, Michael Untch, Nadia Harbeck, et al.
Breast (Edinburgh, Scotland)|May 27, 2025
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitorsRoberta Scafetta, Marco Donato, Carla Gullotta, et al.
Breast (Edinburgh, Scotland)|May 27, 2025
Advancing breast cancer therapy in the era of molecular diagnosticsMaria Grazia Carnevale, Riccardo Ray Colciago, Maria Carmen De Santis, et al.
Breast (Edinburgh, Scotland)|May 22, 2025
Clinical genome sequencing in patients with hereditary breast and ovarian cancer: Concept, implementation and benefitsDennis Witt, Marc Sturm, Antje Stäbler, et al.
Breast (Edinburgh, Scotland)|February 11, 2026
Treatment patterns and clinical outcomes according to PD-L1 status in >2000 patients with early-stage or metastatic triple-negative breast cancer treated in the real-world setting: VANESSA study resultsLazar Popovic, Romualdo Barroso-Sousa, Nagi S El Saghir, et al.
Breast (Edinburgh, Scotland)|February 14, 2026
Surgeon seniority and performance in breast-conserving surgery for non-palpable lesions: evidence from a multicenter studyFabio Corsi, Maria Luisa Gasparri, Sara Albasini, et al.
Breast (Edinburgh, Scotland)|February 4, 2026
Predicting progression-free survival in hormone-receptor positive (HR+/HER2-) metastatic breast cancer (MBC) treated with CDK4/6 inhibitors: A machine learning approachSergio Pannunzio, Luca Mastrantoni, Noemi Maliziola, et al.
Breast (Edinburgh, Scotland)|January 17, 2026
Breast composition and dose deposition to fat and fibroglandular tissues are associated with breast side effects after radiation therapyTanwiwat Jaikuna, Fiona Wilson, Carmel Anandadas, et al.
Breast (Edinburgh, Scotland)|March 22, 2025
Comparison of oncological outcomes of premenopausal with ovarian function suppression versus postmenopausal women in ER+/HER2- breast cancerMin Jung Lee, Ji-Jung Jung, Jong-Ho Cheun, et al.
Breast (Edinburgh, Scotland)|March 16, 2025
Trajectories and predictors of financial toxicity in breast cancer patients: A multicenter longitudinal study in ChinaYi Kuang, Jiajia Qiu, Ye Liu, et al.
Pageof 364